Inhibitory effect of β-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures

Biochemical Pharmacology

Volumn 67, Issue 7, 2004, Pages 1297-1305

  Uchiyama, Satoshi ^a   Yamaguchi, Masayoshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

MEM; minimal essential medium; 1,25 dihydroxyvitamin D3; Lipopolysaccharide; LPS; Parathyroid hormone (1 34); PGE2; Prostaglandin E2; PTH; TNF ; TRACP; Tumor necrosis factor ; VD3

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BUCLADESINE; CALCITRIOL; COLONY STIMULATING FACTOR 1; CRYPTOXANTHIN; CYCLOHEXIMIDE; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE[1-34]; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG MECHANISM; MALE; MOUSE; MULTINUCLEAR CELL; NEWBORN; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

ANIMALS; ANTICARCINOGENIC AGENTS; BETA CAROTENE; BONE MARROW; BONE RESORPTION; CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DRUG INTERACTIONS; MALE; MEMBRANE GLYCOPROTEINS; MICE; OSTEOCLASTS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; XANTHOPHYLLS;

EID: 1542345606     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.11.011     Document Type: Article

References (38)

1. Nishimoto S.K., Chang C.-H., Gendler E., Stryker W.F., Nimni M.E. The effect of aging on bone formation in rats: biochemical and histological evidence for decreased bone formation capacity. Calcif. Tissue Int. 37:1985;617-624.
2. Schapira C., Slinn S., Sarid M., Mokadi S., Kabala A., Silbermann M. Calcium and Vitamin D enriched diets increase and preserve vertebral mineral content in aging laboratory rats. Bone. 16:1995;575-582.
3. Wild R.A., Buchamain J.R., Myers C., Demers L.M. Declining adrenal androgen an association with bone loss in aging women. Proc. Soc. Exp. Biol. Med. 186:1987;335-360.
4. Cooper C., Melton J. III Epidemiology of osteoporosis. Trends Endocrinol. Metab. 3:1995;224-229.
5. Bonjour J.-P., Schurch M.-A., Rozzori R. Nutritional aspects of hip fractures. Bone. 18:1996;1395-1445.
6. Stenmetz K.A., Potter J.D. Vegetable, fruits, and cancer prevention: a review. J. Am. Diet Assoc. 96:1996;1027-1033.
7. Forsyth K.S., Watson R.R., Gensler H.L. Osteotoxicity after chromic dietary administration of 13-cis-retinoic acid, retinyl palmitate or selenium in mice exposed to tumor initiation and promotion. Life Sci. 45:1989;2149-2156.
8. Rohde C.M., Manatt M., Clagett-Dome M., DeLuca H.F. Vitamin A antagonizes the action of Vitamin D in rats. J. Nutr. 129:1999;2241-2250.
9. Promislow J.H.E., Goodman-Gruen D., Slymen D.J., Barret-Connor E. Retinol intake and bone mineral density in the elderly: the rancho bernardo study. J. Bone Miner. Res. 17:2002;1349-1358.
10. Yamaguchi M., Uchiyama S. Effect of carotenoid on calcium content and alkaline phosphatase activity in rat femoral tissues in vitro: the unique anabolic effect of β-cryptoxanthin. Biol. Pharm. Bull. 26:2003;1188-1191.
11. Yamaguchi M, Uchiyama S. β-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro. Mol Cell Biochem 2004; in press.
12. Takahashi N., Yamada H., Yoshiki S., Roodman G.D., Mundy G.R., Jones S.J., Boyde A., Suda T. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology. 122:1998;1373-1382.
13. Mundy GR, Roodman GD. Osteoclast ontogeny and function. In: Peck WA, editor. Bone and mineral research. Amsterdam: Elsevier Science Publishers; 1987. p. 209-79.
14. Burstone M.S. Histochemical demonstration of acid phosphatase with naphthol AS-phosphate. J. Natl. Cancer Inst. 21:1958;523-539.
15. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker osteoclast function. Calcif. Tissue Int. 34:1982;285-290.
16. Takada Y., Kusuda M., Hiura K., Sato T., Mochizuki H., Nagao Y., Tomura M., Yahiro M., Hakeda Y., Kawashima H., Kumegawa M. A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Miner. 17:1992;347-359.
17. Klein-Nulend J., Fall P.M., Raisz L.G. Comparison of the effects of synthetic human parathyroid hormone (PTH)-(1-34)-related peptide of malignancy and bovine PTH-(1-34) on bone formation and resorption in organ culture. Endocrinology. 126:1990;223-227.
18. Klein D.C., Raisz L.G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 86:1990;1430-1440.
19. Meryon S.D., Perris A.D. Lipopolysaccharide-induced bone resorption is mediated by prostaglandins. Life Sci. 28:1981;1061-1065.
20. Klaushofer K., Hoffmann O., Stewart P.J., Czerwenka E., Koller K., Peterlik M., Stern P.H. Cyclosporin A inhibits bone resorption in cultured neonatal calvaria. J. Pharmacol. Exp. Ther. 243:1987;584-590.
21. Kishi S., Yamaguchi M. Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol. 48:1994;1225-1230.
22. Sugimoto T., Kanatani M., Kaji H., Yamaguchi T., Fukase M., Chihara K. Second messenger signaling of PTH- and PTHRP-stimulated osteoclast-like cell formation from hemopoietic blast cells. Am. J. Physiol. 265:1993;E367-E373.
23. Klein-Nulend J., Bowers P.N., Raisz L.G. Evidence that adenosine 3′,5′-monophosphate mediates hormonal stimulation of prostaglandin production in cultured mouse parietal bones. Endocrinology. 126:1990;1070-1075.
24. o sensing in cultured osteoclasts. Am. J. Physiol. 263:1992;C130-C139.
25. Zaidi M., Blair H.C., Moonga B.S., Abe E., Huang C.L.-H. Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J. Bone Miner. Res. 18:2003;599-609.
26. Tanaka S., Nakamura I., Inoue J.-I., Oda H., Nakamura K. Signal transduction pathways regulating osteoclast differentiation and function. J. Bone Miner. Metab. 21:2003;123-133.
27. Gao Y.H., Yamaguchi M. Inhibitory effect of genistein on osteoclast-like cell formation in mouse marrow cultures. Biochem. Pharmacol. 58:1999;767-772.
28. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., Tomoyasu A., Yano K., Goto M., Murakami A., Tsuda E., Morinaga T., Higashino K., Udagawa N., Takahashi N., Suda T. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc. Natl. Acad. Sci. U.S.A. 95:1998;3597-3602.
29. Hsu H., Lacey D.L., Dunstan C.R., Solovyev I., Colombero A., Timms E., Tan H.L., Elliott G., Kelley M.J., Sarosi I., Wang L., Xia X.Z., Elliott R., Chiu L., Black T., Scully S., Capparelli C., Morony S., Shimamoto G., Bass M.B., Boyle W.J. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 96:1999;3540-3545.
30. Burgess T.L., Qian Y., Kaufman S., Ring B.D., Van G., Capparelli C., Kelley M., Hsu H., Boyle W.J., Dunstan C.R., Hu S., Lacey D.L. The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. J. Cell Biol. 45:1999;527-538.
31. Zou W., Hakim I., Tschoep K., Endres S., Bar-Shavit Z. Tumor necrosis factor-α mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism. J. Cell Biochem. 83:2001;70-83.
32. Abu-Amer Y., Bar-Shavift Z. Regulation of TNF-α release from bone marrow-derived macrophages by vitamin D. J. Cell Biochem. 55:1994;435-444.
33. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., Teepe M.C., DuBose R.F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390:1997;175-195.
34. Jimi E., Akiyama S., Tsurukai T., Okahashi N., Kobayashi K., Udagawa N., Nishihara T., Takahashi N., Suda T. Osteoclast differentiation and function. J. Immunol. 163:1999;434-442.
35. Kim H.-H., Kim H.-M., Kwack K., Kim S.W., Lee Z.H. Osteoclast differentiation factor engages the PI 3-kinase, p38, and ERK pathways for avian osteoclast differentiation. J. Biochem. Mol. Biol. 34:2001;421-427.
36. Lee Z.H., Kwack K., Kim K.K., Lee S.H., Kim H.-H. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of NF-κB. Mol. Pharmacol. 58:2000;1536-1545.
37. Lee S.W., Kwak H.B., Chung W.J., Cheong H., Kim H.-H., Lee Z.H. Participation of protein kinase Cββ in osteoclast differentiation and function. Bone. 32:2003;217-227.
38. McEligot A.J., Rock C.L., Shanks T.G., Flatt S.W., Newman V., Faerber S., Pierce J.P. Comparison of serum carotenoid response between women consuming vegetable juice and woman consuming raw or cooked vegetable. Cancer Epideminol. Biomark. Prev. 8:1999;227-231.